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Hip dislocation in cerebral palsy
Teresa Pountney, Elizabeth M Green
The first report on treatment of hip contractures in cer-
ebral palsy was published in 1880.1 Lateral migration of
the hip (subluxation or partial dislocation) occurs in
30-60% of children with cerebral palsy who are not
walking independently at 5 years.2–5 Its clinical course
has been well documented, including its effect on
function (such as pain affecting the ability to sit and
hygiene).w1 We review the literature on current manage-
ment of hip dislocation in cerebral palsy in terms of its
clinical course, measurement, and treatments.
Methods
We searched the major databases including PubMed,
AMED, Embase, CINAHL, and the Cochrane Library
and focused on the prevalence of hip dislocation, its
clinical course, measurement of the condition, and
treatment options. Keywords used were: “cerebral
palsy”, “children”, “hip subluxation or hip dislocation”,
“windswept deformity”, “migration percentage”,
“surgery”, “postural management”, “botulinum toxin”,
and “pain”. The search found little high quality
evidence. Studies were largely cohort or population
studies. We found no systematic reviews and only two
randomised controlled trials and one evidence report
(by the American Academy of Cerebral Palsy and
Developmental Medicine).6–8
Clinical course of hip dislocation
In children with cerebral palsy the hip is normal at
birth but the effects of delayed motor development
lead to dysplasia. Asymmetrical activity of the muscles
surrounding the hip and lack of load bearing affect
bone development and are the main causes of
subluxation and dislocation (figs 1 and 2).w2-w5
Two large studies (93 and 234 participants) investi-
gated pain in adolescents and adults with cerebral
palsy by interview and standardised questionnaires to
identify sites and duration of pain. Thirty nine per cent
and 47% of interviewees reported hip pain at sites of
surgical intervention, which persisted over 20 years.9 10
Several studies reported that dislocated hips were
painful but did not say how this was gauged.w6, w7 In 29
adults with spastic quadriplegic cerebral palsy, 71% of
the 38 dislocated hips were not painful, 11% were
intermittently painful, and only 18% were definitely
painful.w8
Measurement and surveillance
Measuring the percentage of hip migration with an
anteroposterior radiograph is the best way to
determine the degree of subluxation or dislocation of
the hip joint.1 w1 The rate of migration can help deter-
mine risk—an annual migration of 7% or more
correlates with a later inability to walk.w5 The position
of the hip and pelvis at radiography must be consistent
to ensure that sequential radiographs provide reliable
data on changes in hip migration.1 2 A hip is defined as
subluxed if migration is between 33% and 80% and as
dislocated if over 80%.w6 Correlation between hip
abduction and migration percentage is weak, and
migration percentage does not always reflect a child’s
functional and clinical picture, both of which
contribute to decisions on treatment.1 The integrity of
both hips after intervention should be considered; a
successful outcome is one in which both hips are func-
tional and free of pain.
The “paediatric pain profile” is a reliable measure
of pain that can be used before, during, and after inter-
vention to determine outcome.w9 The gross motor
function measure and Chailey levels of ability can
reliably measure functional outcome.11 w10
A hip surveillance programme that developed
from a population based study established factors that
predicted hip problems at 5 years. These risk factors
were migration of 32% or more, had received surgical
intervention, or had been prescribed a hip and spinal
orthosis by an orthopaedic surgeon.2 They recom-
mended a radiograph at baseline for all children with
cerebral palsy not walking 10 steps at 30 months and
Fig 1 Age 3: early migration of right femoral head (left); age 5: progression to dislocation
despite right hip adductor releases (right)
Additional references w1-w23 are on bmj.com
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that children with migration over 15% should be
referred to an orthopaedic consultant. Another hip
surveillance programme recommends a pelvic radio-
graph at 18 months and early preventive soft tissue
surgery to reduce levels of reconstructive bone
surgery.w11
Treatment approaches
Soft tissue and bone surgery are the traditional
treatments, but newer approaches include 24 hour
postural management programmes and injections of
botulinum toxin. These complementary treatments
can be used early on and may reduce or delay the need
for surgery.
The choice of treatment should be based on a clini-
cal assessment that considers the child and the family.
Criteria for interventions should be defined according
to the child’s clinical and functional status, pain levels,
hip migration percentage, and long term prognosis,
the social and emotional implications of these factors,
financial costs, and outcomes.w12
The gross motor function classification system pre-
dicts later motor ability and together with hip
surveillance can identify children at risk of hip
problems.2 w13 This enables conservative approaches
such as postural management to be implemented
before subluxation occurs. If hip migration continues
to worsen, injections of botulinum toxin and surgery
may be needed.
Surgery
Unilateral or bilateral soft tissue surgery aims to
balance the muscle forces across the hip joint and
improve the location of the femoral head in the
acetabulum to prevent further displacement.w1 Soft
tissue surgery can be effective when migration is
between 30% and 50%,w14, w15 although several studies
report the need for further surgery after soft tissue sur-
gery in over 60% of cases.1 w7 The American Academy
of Cerebral Palsy and Developmental Medicine
recently reviewed 27 studies. They found little evidence
for the efficacy of adductor releases owing to the “small
sample sizes, heterogeneous interventions, poorly
defined outcome measures and lack of statistical analy-
sis,” and they identified the need for further research.8
Unilateral bone surgery and soft tissue surgery
cause an alteration in the direction of windsweeping,
which causes increased migration of the contralateral
hip.w16, w17
Bone surgery includes femoral osteotomy, pelvic
osteotomy, and open reduction, which restructure the
proximal femoral and acetabular anatomy to maintain
the position of the hip. Outcomes of bone surgery are
generally good when used to prevent progression of
hip subluxation.w1 A long term review of 63 hips found
that femoral osteotomy alone was not sufficient to keep
the hip centred, and acetabular reconstruction was also
advised.12 Another review supports this finding and
indicates that the development of the acetabulum is
not affected by femoral osteotomy.w1
A prevention programme involving 206 children
with cerebral palsy at 5 years of age reported that none
had developed hip dislocation.13 However, many of
these children were walking, and many had had
surgery (48 soft tissue or bone surgical interventions, 9
selective dorsal rhizotomies, and the insertion of 3
intrathecal baclofen delivery systems).
Many studies on both soft tissue and bone surgery
have a short follow-up, and studies cannot be
compared because they lack valid functional outcomes,
pain is not measured systematically before and after
surgery, or they use different combinations of
procedures.8 13
Long term outcomes of surgery for young adults
need to be considered. A cross sectional study found
that 54% of patients had a windswept deformity
despite hip surgery.w18 A retrospective study of 60 chil-
dren and young adults found that those who had not
had hip surgery had a significantly increased chance of
having both hips undislocated than those who had
received surgery. w19
Surgery causes upheaval in the lives of children
and their families and requires postoperative
Fig 2 Derotational femoral osteotomy to relocate the femoral head
Management of hip dislocation
• Children who are unable to sit unsupported at any
time or walk more than a few paces with the use of
aids (gross motor functional classification system
groups IV-V) should start 24 hour postural
management programmes in lying as soon as
appropriate after birth before hip subluxation occurs,
in sitting from 6 months, and in standing from 12
months11
• All children who cannot walk more than 10 steps by
the age of 30 months should have a hip radiograph to
record the percentage of migration.2 If hip adduction
is pronounced, a radiograph at 18 months may be
helpful
• Repeat radiographs are recommended every 6-12
months until hip migration is stable2
• If migration is greater than 15% at 30 months,
positioning equipment to control posture and referral
to an orthopaedic surgeon are recommended2 11
• An integrated approach to prevent hip problems
should include postural management, botulinum toxin
injections, orthoses, and surgeryw12
• The intervention chosen should have a sound
clinical basis taking into account the child’s clinical and
functional status, pain levels, sleep assessment,
percentage of hip migration, and long term prognosis,
together with the implications of these in social and
emotional terms11
• Training in postural care should be given to all
people directly involved with the child: health
professionals, parents, wheelchair services, education
services, and respite carersw23
Practice
773BMJ VOLUME 332 1 APRIL 2006 bmj.com
rehabilitation. Early intervention programmes, includ-
ing preventive surgery, have reduced the need for more
intensive procedures for hip reconstruction, and
salvage surgery has been virtually eliminated.w10
Managing posture
Equipment to position lying, sitting, and standing is an
established method of maintaining muscle length and
joint range.w20 The widely used kneeblock was first
devised in 1978 to control the hips and pelvis when the
child is seated.11 w21
Twenty four hour approaches to postural manage-
ment have been developed and are now used routinely;
these combine positioning the child during lying,
sitting, and standing to encourage active movement
and function and prevent deformity. Positioning within
the equipment is crucial, and a neutral pelvic position
should be maintained in terms of tilt, rotation, and
obliquity.11
Cohort studies provide limited evidence to support
24 hour postural approaches. A retrospective review of
long term outcomes (using percentage of hip
migration) showed that children given the treatment
before hip subluxation were significantly more likely to
have neither hip subluxed than children who received
treatment after subluxation or not at all.14 A pilot study
of a sleep system (which placed children in a supine
position with hip abduction of 20° bilaterally) on
migration percentage, range of motion, and sleep
found a significant decrease in percentage of hip
migration over one year.15
The evidence for postural management pro-
grammes is limited and further research is needed.
Botulinum toxin
Despite the increasing use of botulinum toxin in manag-
ing migration and reduction of pain in hip subluxation
few published studies exist. Three cohort studies have
investigated the effect of the toxin on pain and
function.16–18 One study found significant increases in the
gross motor function measure and the range of motion
and a decrease in the Ashworth scale (towards a more
normal muscle tone) one month after injection into the
adductor muscles and medial hamstrings.Another study
reviewed the effect of the toxin in 27 children aged 4-19
years with complex disability and chronic, severe pain.
Dramatic improvements were seen in 25 of the children
in tolerating seating and standing supports, sleep, and
toileting. Effects lasted an average of 18 weeks. In
another study, 11 children received a single injection in
the adductor muscle; pain was reduced and function
improved, but no effect was seen on hip migration in
children with over 40% migration.
A randomised controlled trial investigating the
combined effects of injections of botulinum toxin type
A and a variable hip abduction orthosis found greater
improvement in the intervention group.6 A ran-
domised controlled trial on botulinum toxin given
before surgery for hip dislocation found that it reduced
pain after surgery by reducing spasticity.7
Conclusion
Randomised controlled trials may not be the best way
to assess the treatment options for hip dislocation in
cerebral palsy. Instead, studies that profile children to
determine the most appropriate interventions to
reduce the incidence of hip dislocation might provide
more valuable information.w22 We should seek the
views of children and their families on these interven-
tions. Combinations of these approaches might
achieve a long term successful outcome, but this
requires a commitment to collaborative working
between doctors, therapists, and families.
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Additional educational resources
The American Academy of Developmental Medicine
and Child Neurology http://www.aacpdm.org/
index?service = page/Home)—a multidisciplinary
scientific society devoted to the study of cerebral palsy
and other disabilities with childhood onset. It aims to
promote professional education for the management
of these conditions and to improve the quality of life
for people with these disabilities
Information for patients
The National Service Framework for Children, Young
People and Maternity Services (www.dh.gov.uk/
PolicyAndGuidance/HealthAndSocialCareTopics/
ChildrenServices/ChildrenServicesInformation/fs/
en)—establishes clear standards for promoting the
health and wellbeing of children and young people
with disabilities and complex health needs and for
providing high quality services that meet their needs
The Scottish Seating and Wheelchair Group
(www.sswg.scot.nhs.uk/PubDocs/)—a multidisciplinary
organisation that aims to represent all the people who
providing and use wheelchairs and seating within
Scotland
The Association of Paediatric Chartered
Physiotherapists www.csp.org.uk/director/
groupandnetworks/ciogs/clientgroups/
paediatrics.cfm offers information and advice and has
several publications related to cerebral palsy
Summary points
Reliable measures of pain, hip migration, and
function in cerebral palsy are now available
Options other than surgery, such as postural
management and injections of botulinum toxin,
offer less invasive approaches to managing hip
dislocation but need long term evaluation
Because of the heterogeneity and complex
disability in these children, profiling children
rather than using randomised controlled trials
might identify which interventions reduce the
incidence of hip dislocation
Combined approaches might be successful in the
long term, but they require collaboration between
doctors, therapists, and families
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Lesson of the week
Secondary drowning in a patient with epilepsy
Stephanie Milne, Andrew Cohen
Drowning is defined as death by suffocation after sub-
mersion in a liquid; near drowning is survival, at least
temporarily, after aspiration of fluid into the lungs.1 2
Secondary drowning is death or serious clinical
deterioration following near drowning after a period of
relative wellbeing; it is not due to neurological causes,
respiratory sequelae of inhaled foreign material, or
secondary infection. Secondary drowning is caused by
inadequate alveolar gas exchange, probably due to pri-
mary alveolar membrane dysfunction and loss of
surfactant. It can happen after immersion in fresh
water or salt water.3–5 Secondary drowning occurs in
2-5% of all submersion incidents.6 7
We report a patient who seemed to recover fully
from near drowning. The diagnosis of secondary
drowning was not made until several hours after
admission with acute respiratory distress. We highlight
the need to consider secondary drowning and describe
its immediate care, diagnosis, and management.
Case report
A 44 year old woman with a history of hypertension
and epilepsy had a tonic-clonic seizure while
swimming unaccompanied in her local pool. She was
submerged for about one minute then taken to the side
of the pool, where the seizure continued for two
minutes before stopping spontaneously. She seemed to
recover fully and refused offers to be taken to the hos-
pital, preferring to go home.
About an hour and a half after returning home she
developed shortness of breath, chest pain, and a cough
that produced pink frothy sputum. Her general practi-
tioner was called. Her oxygen saturation was 80% and
she was given 50 mg of furosemide. An ambulance was
called and she had a second tonic-clonic seizure in the
ambulance. On arrival in the accident and emergency
department she was deeply unconscious with a
Glasgow Coma Scale of 3/15 and a rigid decorticate
posture. She had a further tonic-clonic seizure, which
was treated with lorazepam 4 mg intravenously. Vital
signs were respiratory rate of 26 breaths/min,
temperature of 38.5°C, blood pressure of 177/118 mm
Hg, and pulse rate of 124 beats/min. On auscultation
of the chest, bilateral coarse crepitations were audible
throughout both lung fields.
Because of her depressed level of consciousness
and the risk of obstruction to ventilation or aspiration
of stomach contents, she was given intravenous
thiopentone 200 mg and suxamethonium 100 mg and
intubated using an 8.0 mm oral tracheal tube. After
intubation, pink frothy sputum was aspirated from the
endotracheal tube. A nasogastric tube was also placed.
The patient was subsequently ventilated with 80% oxy-
gen and 8 cm H2O PEEP (positive end expiratory pres-
sure). Her oxygen saturation rose to 92%. She was
given a further 100 mg of furosemide, which increased
oxygen saturation to 100%.
Initially the pulmonary oedema was thought to
have a cardiogenic or neurogenic cause. A chest radio-
graph was consistent with pulmonary oedema, and an
echocardiogram performed in the accident and emer-
gency department showed concentric left ventricular
hypertrophy with good left ventricular function and
slight septal dysfunction. A computed tomogram of
the brain was normal. Serum chemistry and haema-
tology were within normal ranges except for mild
hyponatraemia (sodium 133 mmol/l) and leucocytosis
(13.98×109/l). The patient was transferred to theatre
recovery before being admitted to intensive care as no
bed was immediately available. She was initially sedated
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